MITF and neoplasm: Intriguingly, MITF heterogeneity can be detected throughout progression and can even be found in circulating tumour cell clusters (Khoja et al, 2014), suggesting that maintaining heterogeneity throughout tumour progression is beneficial for the establishment of advanced disease.